Erratum: Opioid-induced hyperaigesia (Journal of the Korean Medical Association (2014) 57, 1 (41-46) DOI:10.5124/jkma.2014.57.1.41);Opioid-induced hyperalgesia

Journal of the Korean Medical Association

Volumn 57, Issue 1, 2014, Pages 41-46

  Lee, Heeseung ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Drug tolerance; Hyperalgesia; Opioid

Indexed keywords

DYNORPHIN; N METHYL DEXTRO ASPARTIC ACID; OPIATE; REMIFENTANIL;

ANALGESIA; ANESTHESIA; ARTICLE; DRUG MEGADOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; HYPERALGESIA; INTRACELLULAR SIGNALING; NOCICEPTION; PAIN ASSESSMENT; PEROPERATIVE COMPLICATION; QUALITY OF LIFE; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; STIMULUS RESPONSE; SURGICAL PATIENT; TREATMENT DURATION;

EID: 84894118493     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2014.57.3.270     Document Type: Erratum

References (13)

1. Siegel S, Hinson RE, Krank MD, McCully J. Heroin "overdose" death: contribution of drug-associated environmental cues. Science 1982;216:436-437.
2. Kissin I, Bright CA, Bradley EL Jr. Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems. Anesth Analg 2000;91:110-116.
3. Adam F, Bonnet F, Le Bars D. Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist. Neuropharmacology 2006;51:191-202.
4. Trafton JA, Abbadie C, Marek K, Basbaum AI. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci 2000;20:8578-8584.
5. Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan TP Jr, Lai J, Porreca F. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002;22:6747-6755.
6. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998;86:1307-1311.
7. Gustorff B, Nahlik G, Hoerauf KH, Kress HG. The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg 2002;94:1223-1228.
8. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000;93:409-417.
9. Crawford MW, Hickey C, Zaarour C, Howard A, Naser B. Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg 2006; 102:1662-1667.
10. Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001;87:866-869.
11. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-815.
12. Hansen EG, Duedahl TH, Romsing J, Hilsted KL, Dahl JB. Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol Scand 2005;49:1464-1470.
13. Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005; 102:398-402.